Inventor · disambiguated record
Yan Fu
Also filed as: FU YAN · Fu yan-fang
22 granted patents·20 pending applications·131 citations·filing 2000–2023
94Inventor score
Top patents by PatentIndex Score
42 records- 0197US10119133B2Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editingMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Nov 6, 2018·39 cites·11 claims
- 0295US7442371B2Recombinant human albumin-erythropoietin fusion proteins with long-lasting biological effectsYU ZAILIN·Filed 2007·Granted Oct 28, 2008·21 cites·7 claims
- 0394US8084021B2Recombinant human albumin-interleukin-11 fusion protein with long-lasting biological effectsYU ZAILIN·Filed 2008·Granted Dec 27, 2011·19 cites·5 claims
- 0493US7244833B2Recombinant human albumin fusion proteins with long-lasting biological effectsYU ZAILIN·Filed 2003·Granted Jul 17, 2007·32 cites·17 claims
- 0583US8603973B2Skincare composition comprising HSA fusion protein, preparation method and uses thereofFU YAN·Filed 2008·Granted Dec 10, 2013·5 cites·14 claims
- 0677US7572437B2Long acting human interferon analogsFU YAN·Filed 2004·Granted Aug 11, 2009·6 cites·14 claims
- 0775US9114094B2Method of use and preparation of HSA fusion protein composition for skincareFU YAN·Filed 2013·Granted Aug 25, 2015·2 cites·15 claims
- 0871US9637454B2Fluorine substituted cyclic amine compounds and preparation methods, pharmaceutical compositions, and uses thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2013·Granted May 2, 2017·2 cites·19 claims
- 0970US2009280085A1Long Acting Human Interferon AnalogsFU YAN·Filed 2009·Application pending·0 cites
- 1068US6428961B1Nucleic acid molecules encoding histidine tags in three reading framesFiled 2000·Granted Aug 6, 2002·1 cites·24 claims
- 1165US10647968B2Endostatin mutants with mutations at ATP binding sitesLUO YONGZHANG·Filed 2012·Granted May 12, 2020·1 cites·6 claims
- 1264US2022409703A1Drug for inhibiting adipose cell differentiation and insulin resistanceUNIV TSINGHUA·Filed 2022·Application pending·0 cites
- 1363US10131618B2Process for the preparation of spiro[2.5]octane-5,7-dione and spiro[3.5]nonane-6,8-dioneBOEHRINGER INGELHEIM INT·Filed 2018·Granted Nov 20, 2018·0 cites·1 claims
- 1463US8796285B2Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereofZHANG HAILIN·Filed 2010·Granted Aug 5, 2014·3 cites·3 claims
- 1563US2025376525A1Pharmaceutical composition comprising mixed antibody of anti-ctla4 and anti-pd1 and therapeutic use thereofQILU PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1661US7056672B2Method of identifying an open reading frame using a nucleic acid molecule encoding multiple start codons and histidine tagsUNIV IOWA STATE RES FOUND INC·Filed 2004·Granted Jun 6, 2006·0 cites·10 claims
- 1760US8975030B2Method for cancer detectionUNIV TSINGHUA·Filed 2013·Granted Mar 10, 2015·0 cites·12 claims
- 1860US2012128624A1Recombinant Human Albumin-Granulocyte Macrophage Colony Stimulating Factor Fusion Protein With Long-Lasting Biological EffectsYU ZAILIN·Filed 2011·Application pending·0 cites
- 1958US10054590B2Use of nucleolin as a biomarker for lymphangiogenesis in a cancer prognosis and therapyUNIV TSINGHUA·Filed 2013·Granted Aug 21, 2018·0 cites·18 claims
- 2058US9815906B2Method of inhibiting or treating cancer metastasisUNIV TSINGHUA·Filed 2015·Granted Nov 14, 2017·0 cites·5 claims
- 2157US9938228B2Process for the preparation of spiro[2.5]octane-5,7-dione and spiro[3.5]nonane-6,8-dioneBOEHRINGER INGELHEIM INT·Filed 2015·Granted Apr 10, 2018·0 cites·1 claims
- 2256US2010184661A1Conjugate comprising angiostation or its fragment, the method for producing the conjugate and use thereofPROTGEN LTD·Filed 2008·Application pending·0 cites
- 2355US9145452B2Application of fibrinogen-420 and its active domainUNIV TSINGHUA·Filed 2013·Granted Sep 29, 2015·0 cites·9 claims
- 2454US2006051859A1Long acting human interferon analogsFU YAN·Filed 2004·Application pending·0 cites
- 2553US8389684B2Tumor biomarkerLUO YONGZHANG·Filed 2010·Granted Mar 5, 2013·0 cites·3 claims
- 2653US2024075105A1Fusion Protein of Human Serum Albumin and Interleukin-2, and Use ThereofSINOBIOTECH TIANJIN LTD·Filed 2021·Application pending·0 cites
- 2750US2010285103A1Medicament for treatment of tumors and the use thereofLUO YONGZHANG·Filed 2007·Application pending·0 cites
- 2849US2014056966A1Conjugate angiostation or its fragment, the method of producing the conjugate and use thereofLUO YONGZHANG·Filed 2012·Application pending·0 cites
- 2948US6709863B2Nucleic acid molecules encoding multiple start codons and histidine tagsUNIV IOWA RES FOUND INC·Filed 2001·Granted Mar 23, 2004·0 cites·14 claims
- 3048US2023265166A1Young and undamaged human serum albumin improves longevity of humanSHENZHEN PROTGEN LTD·Filed 2021·Application pending·0 cites
- 3148US2013023479A1Use of nucleolin as a biomarker for lymphangiogenesis in cancer prognosis and therapyPROTGEN LTD·Filed 2012·Application pending·0 cites
- 3247US2018360922A1Medicament for treatment of tumors and the use thereofUNIV TSINGHUA·Filed 2018·Application pending·0 cites
- 3346US9364493B2Methods and compositions for enhancing the uptake of therapeutic agents by target cellsLUO YONGZHANG·Filed 2012·Granted Jun 14, 2016·0 cites·14 claims
- 3446US2016178633A1Tumor biomarkerUNIV TSINGHUA·Filed 2014·Application pending·0 cites
- 3545US2025186598A1Recombinant human serum albumin-collagen binding domain fusion protein for tumor-specific targeting matrix, and use thereofHUATONG FORTURN CHINA CO LTD·Filed 2020·Application pending·0 cites
- 3645US2018094051A1Method for inhibiting lymphangiogenesis by administration of an inhibitor of the cxcl12 pathwayUNIV TSINGHUA·Filed 2017·Application pending·0 cites
- 3744US2023390364A1Use of human serum albumin in treatment of diseasesSHENZHEN PROTGEN LTD·Filed 2021·Application pending·0 cites
- 3843US10106506B2General process for the preparation of 6-substituted or 5,6-disubstituted derivatives of 2-amino-isonicotinic acidBOEHRINGER INGELHEIM INT·Filed 2016·Granted Oct 23, 2018·0 cites·13 claims
- 3940US2012165510A1novel application of fibrinogen-420 and its active domainYONGZHANG LUO·Filed 2010·Application pending·0 cites
- 4038US2018015148A1Drug for inhibiting adipose cell differentiation and insulin resistanceUNIV TSINGHUA·Filed 2015·Application pending·0 cites
- 4134US2014193424A1Method and medicament for inhibiting lymphangiogenesisBEIJING PROTGEN LTD·Filed 2013·Application pending·0 cites
- 4231US2019200554A1Compositions and Methods for Plant Haploid InductionMONSANTO TECHNOLOGY LLC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yan Fu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →